|
Dr. Louis Weiner was quoted by the Wall Street Journal, Bloomberg, International Business Times and OncLive about the FDA's approval of the first "biosimilar" drug.
Dr. Aline Charabaty was interviewed by the Wall Street Journal for a second story on biosimilars.
Oncology Times and The Cancer Letter quoted Dr. Weiner on the announced departure of NCI Director Harold Varmus.
Catholic News Agency turned to Dr. Victoria Jennings for a story on natural family planning.
In an interview with The Hoya, Dr. Michael Stoto commented on Ron Klain's term as "Ebola czar."
Dr. Jesse Goodman discusses what's known about long-term effects of #Ebola survivors with LiveScience.
NPR All Things Considered reported on an NHS alumni brother/sister Ebola fighting team.
LiveScience interviewed Dr. Jesse Goodman about preventing antibiotic resistance.
Dr. Sally Joo Bailey joined a panel on the Diane Rehm Show to discuss latest research on peanut allergies.
Dr. Paul Roepe was interview by NPR for a web story about hand sanitizers and Ebola.
Dr. James Giordono went on Al Jazeera's The Stream to discuss psychedelic drug research.
USA Today interviewed Dr. Joel Selanikio about statements made by Ebola survivor Craig Spencer.
Dr. Charbel Moussa commented on WUSA-9 on research involving a skin test to diagnose neurologic disorders.
Research conducted by Dr. Michael Stoto and colleagues on the Elk River Spill was included in the Harvard Friday Letter.
Dr. Alfiee Breland-Noble discusses funding opportunities via PCORI in Monitor on Psychology.
Dr. Kevin FitzGerald talked to PolitiFact at the Atlanta Journal Constitution about a new bill to curb human-animal hybrids.
Howard University News Service interviewed Dr. Ranit Mishori for a story on symptoms of menopause.
Dr. Bruce Cheson comments on Medscape on over-testing involving lymphoma.
ALN magazine reported on Dr. Kathyrn Sandberg's publication offering recommendations to the NIH for sex diversity in research.
| 
